Acalabrutinib in patients (pts) with Waldenstrom macroglobulinemia (WM).

Owen, R; McCarthy, H; Rule, S; D'Sa, S; Thomas, SK; Forconi, F; Anderson, TC; Kersten, MJ; Zinzani, PL; Iyengar, S; Kothari, J; Minnema, M; Kastritis, E; Izumi, R; Slatter, JG; Mittag, D; Wei, H; Chen, DY; Patel, P; Furman, RR

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):